Cargando…

Hub genes in a pan-cancer co-expression network show potential for predicting drug responses

Background: The topological analysis of networks extracted from different types of “omics” data is a useful strategy for characterizing biologically meaningful properties of the complex systems underlying these networks. In particular, the biological significance of highly connected genes in diverse...

Descripción completa

Detalles Bibliográficos
Autores principales: Azuaje, Francisco, Kaoma, Tony, Jeanty, Céline, Nazarov, Petr V., Muller, Arnaud, Kim, Sang-Yoon, Dittmar, Gunnar, Golebiewska, Anna, Niclou, Simone P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000 Research Limited 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6406180/
https://www.ncbi.nlm.nih.gov/pubmed/30881689
http://dx.doi.org/10.12688/f1000research.17149.2
_version_ 1783401241370427392
author Azuaje, Francisco
Kaoma, Tony
Jeanty, Céline
Nazarov, Petr V.
Muller, Arnaud
Kim, Sang-Yoon
Dittmar, Gunnar
Golebiewska, Anna
Niclou, Simone P.
author_facet Azuaje, Francisco
Kaoma, Tony
Jeanty, Céline
Nazarov, Petr V.
Muller, Arnaud
Kim, Sang-Yoon
Dittmar, Gunnar
Golebiewska, Anna
Niclou, Simone P.
author_sort Azuaje, Francisco
collection PubMed
description Background: The topological analysis of networks extracted from different types of “omics” data is a useful strategy for characterizing biologically meaningful properties of the complex systems underlying these networks. In particular, the biological significance of highly connected genes in diverse molecular networks has been previously determined using data from several model organisms and phenotypes. Despite such insights, the predictive potential of candidate hubs in gene co-expression networks in the specific context of cancer-related drug experiments remains to be deeply investigated. The examination of such associations may offer opportunities for the accurate prediction of anticancer drug responses.  Methods: Here, we address this problem by: a) analyzing a co-expression network obtained from thousands of cancer cell lines, b) detecting significant network hubs, and c) assessing their capacity to predict drug sensitivity using data from thousands of drug experiments. We investigated the prediction capability of those genes using a multiple linear regression model, independent datasets, comparisons with other models and our own in vitro experiments. Results: These analyses led to the identification of 47 hub genes, which are implicated in a diverse range of cancer-relevant processes and pathways. Overall, encouraging agreements between predicted and observed drug sensitivities were observed in public datasets, as well as in our in vitro validations for four glioblastoma cell lines and four drugs. To facilitate further research, we share our hub-based drug sensitivity prediction model as an online tool. Conclusions: Our research shows that co-expression network hubs are biologically interesting and exhibit potential for predicting drug responses in vitro. These findings motivate further investigations about the relevance and application of our unbiased discovery approach in pre-clinical, translationally-oriented research.
format Online
Article
Text
id pubmed-6406180
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher F1000 Research Limited
record_format MEDLINE/PubMed
spelling pubmed-64061802019-03-15 Hub genes in a pan-cancer co-expression network show potential for predicting drug responses Azuaje, Francisco Kaoma, Tony Jeanty, Céline Nazarov, Petr V. Muller, Arnaud Kim, Sang-Yoon Dittmar, Gunnar Golebiewska, Anna Niclou, Simone P. F1000Res Research Article Background: The topological analysis of networks extracted from different types of “omics” data is a useful strategy for characterizing biologically meaningful properties of the complex systems underlying these networks. In particular, the biological significance of highly connected genes in diverse molecular networks has been previously determined using data from several model organisms and phenotypes. Despite such insights, the predictive potential of candidate hubs in gene co-expression networks in the specific context of cancer-related drug experiments remains to be deeply investigated. The examination of such associations may offer opportunities for the accurate prediction of anticancer drug responses.  Methods: Here, we address this problem by: a) analyzing a co-expression network obtained from thousands of cancer cell lines, b) detecting significant network hubs, and c) assessing their capacity to predict drug sensitivity using data from thousands of drug experiments. We investigated the prediction capability of those genes using a multiple linear regression model, independent datasets, comparisons with other models and our own in vitro experiments. Results: These analyses led to the identification of 47 hub genes, which are implicated in a diverse range of cancer-relevant processes and pathways. Overall, encouraging agreements between predicted and observed drug sensitivities were observed in public datasets, as well as in our in vitro validations for four glioblastoma cell lines and four drugs. To facilitate further research, we share our hub-based drug sensitivity prediction model as an online tool. Conclusions: Our research shows that co-expression network hubs are biologically interesting and exhibit potential for predicting drug responses in vitro. These findings motivate further investigations about the relevance and application of our unbiased discovery approach in pre-clinical, translationally-oriented research. F1000 Research Limited 2019-03-05 /pmc/articles/PMC6406180/ /pubmed/30881689 http://dx.doi.org/10.12688/f1000research.17149.2 Text en Copyright: © 2019 Azuaje F et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Azuaje, Francisco
Kaoma, Tony
Jeanty, Céline
Nazarov, Petr V.
Muller, Arnaud
Kim, Sang-Yoon
Dittmar, Gunnar
Golebiewska, Anna
Niclou, Simone P.
Hub genes in a pan-cancer co-expression network show potential for predicting drug responses
title Hub genes in a pan-cancer co-expression network show potential for predicting drug responses
title_full Hub genes in a pan-cancer co-expression network show potential for predicting drug responses
title_fullStr Hub genes in a pan-cancer co-expression network show potential for predicting drug responses
title_full_unstemmed Hub genes in a pan-cancer co-expression network show potential for predicting drug responses
title_short Hub genes in a pan-cancer co-expression network show potential for predicting drug responses
title_sort hub genes in a pan-cancer co-expression network show potential for predicting drug responses
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6406180/
https://www.ncbi.nlm.nih.gov/pubmed/30881689
http://dx.doi.org/10.12688/f1000research.17149.2
work_keys_str_mv AT azuajefrancisco hubgenesinapancancercoexpressionnetworkshowpotentialforpredictingdrugresponses
AT kaomatony hubgenesinapancancercoexpressionnetworkshowpotentialforpredictingdrugresponses
AT jeantyceline hubgenesinapancancercoexpressionnetworkshowpotentialforpredictingdrugresponses
AT nazarovpetrv hubgenesinapancancercoexpressionnetworkshowpotentialforpredictingdrugresponses
AT mullerarnaud hubgenesinapancancercoexpressionnetworkshowpotentialforpredictingdrugresponses
AT kimsangyoon hubgenesinapancancercoexpressionnetworkshowpotentialforpredictingdrugresponses
AT dittmargunnar hubgenesinapancancercoexpressionnetworkshowpotentialforpredictingdrugresponses
AT golebiewskaanna hubgenesinapancancercoexpressionnetworkshowpotentialforpredictingdrugresponses
AT niclousimonep hubgenesinapancancercoexpressionnetworkshowpotentialforpredictingdrugresponses